Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

Clinical trial NCT00548171 · COMPLETED

Trial details

NCT number: NCT00548171
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria Diphtheria-Tetanus-acellular Pertussis Vaccines

Start date: 2007-11-05
Primary completion: 2008-04-30
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.